A fortnightly podcast to update ESF pharmacists on the latest news in pharmacy, summarise the evidence of clinical trials, and share some ideas for your patients and help your practice.
Information about how Cannabis works, different types of cannabinoids as well as importance of terpenes
3 Jun 2021
ESF podcast - Leaders Day Summary - Dispensary Efficiencies
A summary of dispensary efficiencies discussed at Leaders Day 5th May 2021.
1 Feb 2021
ESF Podcast - February 2021. COVID-19 Vaccines and pharmacies
This episode is a summary of the 2 main COVID-19 vaccines distributed first in Australia, and how pharmacies in Australia will be involved, coinciding with Flu season 2021
This episode discusses the new NICE draft guidelines, new warnings on Hydrochlorothiazide, new opinions on metformin use in pre-diabetes, a new once weekly insulin is being trialled, and I talk to Bec from Activated Probiotics about Biome Lift. The draft guideline can be viewed at www.nice.org.uk/guidance/gid-ng10069/documents/draft-guideline
A trial to determine medicinal cannabis user's perception of benefit, update on risk of hydroxychloroquine and macrolide combination, theory of immunosuppression for COVID-19 management, and potential barriers to deprescribing as described by GPs.
20 May 2020
ESF Podcast - 22nd May. Apixaban vs rivaroxaban, SGLT2 inhibitors, ACEI and ARBs & flu risk
Apixaban vs rivaroxaban in non-valvular AF, SGLT2 inhibitors and renal dysfunction risk, ACEI and ARBs use and risk of influenza, update on Medadvisor signups, and a free course from the ASHP.
7 May 2020
ESF Podcast - Week starting 4th May - apixaban evidence, glucosamine, vitamin B6 and SAS processes
Apixaban study on outcomes regardless of stroke history, glucosamine allergy and effects on blood glucose level, warninhs over low doses of vitamin B6 and how to access products from the SAS.
23 Apr 2020
Week starting 20th April - Mental health and COVID-19, update on HCQ and changes to 6CPA programs
Updates on mental health during times of COVID-19 including self-care and clozapine, update on Hydroxychloroquine studies, and changes to medscheck and HMR/RMMR programs
9 Apr 2020
Week starting 6th April, 2020 - COVID-19 and ibuprofen, hydroxychloroquine and frailty risk
An update on why a recommendation was made to avoid ibuprofen in COVID-19 infection, is hydroxychloroquine really the magic drug to rid us of this horrible scourge, and new evidence suggests our elderly patients in isolation may be at an accelerated risk of frailty. Link as mentioned in episode: https://www.cebm.net/covid-19/maximising-mobility-in-the-older-people-when-isolated-with-covid-19/
Host of ESF Pharmacists Podcast?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
